News
-
Latest Research on Sarm Products
Research on Breast Cancer Treatment Enobosarm: A multicenter, open-label, randomized, parallel, phase II study demonstrated that for the treatment of ER+ advanced breast cancer with oral Sarm enobosarm, the clinical benefit rate in the 9mg group was 25.0% at 24 weeks, and that in the 18mg group...Read more -
Enterprise News Promotion: Creating Value, Cohesion and Influence
I. Creating Value Through enterprise news promotion, an enterprise can convey its values, mission and development strategy to the outside world. By releasing enterprise news, the enterprise can display its competitive advantages in the market, increase brand exposure and attract more pot...Read more -
A New Chapter in Development: The Industry – Trade Integrated Company in API, Food Supplements and Fine Chemicals Field
In a highly competitive global market, the company is a shining star, demonstrating exceptional strength in active pharmaceutical ingredients (apis), food supplements and other fine chemicals. We are proud to announce that as an industry-trade integrated enterprise, we are setting a new...Read more -
Uniting Team Strength, Creating Corporate Glory Together – The Company Successfully Held a Team Building Sports Meeting
On Tuesday, November 12th, 2024, the company successfully held the “Healthy Companions, Fun Team Building – Staff Fun Sports Meeting”. This event received active responses from the staff of all departments. It not only strengthened the centripetal force and cohesion of t...Read more -
Pharmaceutical Intermediates are an Important Part of the Fine Chemical Industry
The Connotation of Fine Chemicals Fine chemicals refer to the abbreviation of the industry that produces fine chemicals in the chemical industry. They are small-batch, high-performance chemicals that can enhance or endow a (type of) product with specific functions or possess specific fu...Read more -
With Excellent Quality as the Engine: Opening a New Chapter of High – quality Development
Adhering to the core concept of “strengthening quality support and building a strong country with quality”, the company takes active actions to continue to provide customers with a full range of services covering quality, standards, technology and brands, leading a new journ...Read more -
The Status of Chemical Research can be Summarized
Research level China’s chemical research has been at the forefront of the world. He has made important achievements in polymer science, material chemistry, physical chemistry, biochemistry and many other fields. After long-term efforts, China’s chemical research has develope...Read more -
Company Industry Profile
The company is a highly competitive modern advanced enterprise in the industry, specializing in the production and export of apis, peptides, plant extracts and other products. The company has first-class production facilities and exquisite production technology, and every link strictly f...Read more -
Join hands and walk together to create the future – Team Building and Outward Bound Activity.
In order to further enhance the cohesion, combat effectiveness and centripetal force of young workers, enrich the leisure cultural life of young workers, and better stimulate the work passion of young workers, the company organized a group building expansion activity with the theme of &...Read more -
Steroid Products Research
China Steroid corticosteroid Industry Market research report covers the statistics of the historical market data in the past five years and the forecast of the future market capacity growth trend. The global steroid corticosteroid market size reached 32.024 billion yuan (RMB), and the Chinese ste...Read more -
Liraglutide
Since Liraglutide and Semiglutide have become “explosive”, the weight loss track has been regarded as the new blue ocean of biomedicine. On June 13, Hong Kong-listed company China Biopharmaceutical (01177.HK) announced that it has reached a cooperation agreement with Hongyun Huining (...Read more -
Retatrutide
Retatrutide Tilpotide is the best weight-loss drug among the GLP-1 drugs that have been developed. In the Phase III SURMOUNT-1 study of obese subjects without type 2 diabetes, after 72 weeks of treatment with tilpotide, participants in the 15mg dose group lost an average of up to 22.5% (24 kg) of...Read more